StimTrial Neuromodulation System
Stimulator, Peripheral Nerve, Implanted (Pain Relief). 510(k) K253877, from Bioventus, LLC (Durham, NC). Product code GZF, class 2.
As of Nov 21, 2026, K253877 is an FDA 510(k) held by Bioventus, LLC, substantially equivalent on Aug 26, 2026 after 265 days, with no recalls tied to it in FDA's recall database.
- Review time: 265 days
- Recalls: 0
The StimTrial System is indicated for trial stimulation (no longer than 30 days) to determine efficacy before recommendation for either the StimRouter Neuromodulation System’s or the TalisMann Neuromodulation System’s permanent (long term) implant indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as an adjunct to other modes of therapy…
- StimTrial Neuromodulation SystemK243782 · Bioventus, LLC · Jul 16, 2025
- TalisMann Neuromodulation SystemK243678 · Bioventus, LLC · Jul 3, 2025
- Nalu Neurostimulation System for Peripheral Nerve StimulationK232415 · Boston Scientific Neuromodulation · Aug 21, 2024
- Freedom Peripheral Nerve Stimulator (PNS) SystemK233162 · Curonix · Jun 20, 2024
- Neuspera Nuity SystemK221303 · Neuspera Medical, Inc. · Apr 11, 2023
- StimRouter Neuromodulation SystemK211965 · Bioness, Inc. · Feb 23, 2022
- Neuspera Neurostimulation System (NNS)K202781 · Neuspera Medical, Inc. · Aug 27, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Dec 4, 2025
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5870
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files